Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Drugs
Pharma